Safety and efficacy of standard of care ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM): real world experience

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览10
暂无评分
关键词
relapsed/refractory multiple myeloma,multiple myeloma,care ciltacabtagene,rrmm,cilta-cel
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要